Tuesday, 13 August 2019

Deciphera's late-stage study meets main goal of preventing cancer progression

Deciphera Pharmaceuticals Inc said on Tuesday its late-stage study met the main goal of preventing cancer from progressing in patients with a form of stomach cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)